Continuous Glucose Monitoring: TheraSense Targets Medtronic/MiniMed
TheraSense expects its continuous glucose monitoring system to compete on clinical chemistry and device size improvements in the diabetes market by mid-2004
TheraSense expects its continuous glucose monitoring system to compete on clinical chemistry and device size improvements in the diabetes market by mid-2004